Sila Realty Trust Reports Mixed Q4 & Full-Year 2025 Results with Declining Net Income Amidst Continued Acquisitions

summarizeSummary

Sila Realty Trust, Inc. reported a significant decline in GAAP net income for both the fourth quarter and full year 2025, alongside a modest decrease in full-year Adjusted Funds From Operations (AFFO) per diluted share. While the company demonstrated operational strength with increased Cash Net Operating Income (NOI) and a slight rise in Q4 AFFO per diluted share, the overall profitability metrics present a mixed picture. The company continues to execute its growth strategy through substantial healthcare property acquisitions in 2025 and early 2026, and maintains a robust balance sheet with considerable liquidity. Investors should carefully assess the declining GAAP profitability against the backdrop of strategic growth initiatives and stable dividend payouts.

check_boxKey Events

• Q4 2025 Financial Performance

  Reported net income of $5.0 million ($0.09 per diluted share), a significant decrease from $11.1 million ($0.20 per diluted share) in Q4 2024. Adjusted Funds From Operations (AFFO) slightly increased to $30.4 million ($0.55 per diluted share) from $30.2 million ($0.54 per diluted share) year-over-year.

• Full Year 2025 Financial Performance

  Full-year net income was $33.1 million ($0.60 per diluted share), down from $42.7 million ($0.75 per diluted share) in 2024. Full-year AFFO decreased to $120.9 million ($2.18 per diluted share) from $131.1 million ($2.31 per diluted share) in 2024.

• Operational Cash Flow Growth

  Cash Net Operating Income (NOI) increased to $44.0 million in Q4 2025 from $41.0 million in Q4 2024, and to $169.9 million for the full year 2025 from $168.6 million in 2024.

• Strategic Acquisitions

  Acquired six healthcare properties for an aggregate purchase price of $148.9 million in 2025. Post-period, the company acquired an additional inpatient rehabilitation facility for $43.1 million in January 2026.

auto_awesomeAnalysis

Sila Realty Trust, Inc. reported a significant decline in GAAP net income for both the fourth quarter and full year 2025, alongside a modest decrease in full-year Adjusted Funds From Operations (AFFO) per diluted share. While the company demonstrated operational strength with increased Cash Net Operating Income (NOI) and a slight rise in Q4 AFFO per diluted share, the overall profitability metrics present a mixed picture. The company continues to execute its growth strategy through substantial healthcare property acquisitions in 2025 and early 2026, and maintains a robust balance sheet with considerable liquidity. Investors should carefully assess the declining GAAP profitability against the backdrop of strategic growth initiatives and stable dividend payouts.